Credit where it is due, PR and Co. have really structured things in a way to help turn things around in the most dramatic way possible. A brilliant way to top things off will be a partnership deal. Just imagine if PR announces a China deal in the next two weeks? Unlikely, but wouldn't it just top things off nicely?
MRI results in conjunction with all other results confirm DMOAD. I must admit that I only expected an improvement to BML at 6 months and no improvement in cartilage at 6 months since it just seemed too soon. iPPS basically now ticks all the boxes; pain and function, biomarkers, durability, mri etc. We can also expect a favourable outcome at the upcoming FDA meeting in Q1.
GLTAH
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-83
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $71.79M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $40.95K | 203.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 9204 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 44989 | 7 |
View Market Depth
| Last trade - 12.19pm 02/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |